2m 2m 2m 2m 2m 2m 2m
Corvus Pharmacet (CRVS)
NASDAQ
$13.06+$0.005 (+0.04%)
Price as of Jun 25, 2026 5:39 PM EDT- $1.1BMarket Cap
- 214.32%1-Year Change
- BiotechnologyIndustry
Corvus Pharmacet (CRVS)
$13.06+$0.005 (+0.04%)
CRVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.05 | ||
Change | +$0.10 (+0.77%) | ||
Open | $12.76 | ||
High | $13.52 | ||
Low | $12.76 | ||
Previous Close | $12.95 | ||
Volume | 1,311,110 | ||
30-Day Average Volume | 1,371,020 | ||
1-Week Change | 9.57% | ||
1-Month Change | 3.49% | ||
1-Year Change | 209.98% | ||
3-Year Change | 495.89% | ||
5-Year Change | 359.51% | ||
Fundamentals | |||
Shares Outstanding | 84.1M | ||
Total Assets | $253.2M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.7M | ||
Free Cash Flow | -$10.5M | ||
EBIT | -$13.7M | ||
EBITDA | -$13.7M | ||
Net Working Capital | $227.8M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -77 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -86 | ||
PEG | 75 | ||
Price/Free Cash Flow | -104 | ||
Price/Operating Cash Flow | -105 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue